ADB-5'Br-PINACA

ADB-5'Br-PINACA_structure.png

ADB-5'Br-PINACA is a synthetic cannabinoid that belongs to the indazole-3-carboxamide family. It is a potent agonist of the cannabinoid receptors, specifically the CB1 and CB2 receptors. This compound has been identified in various synthetic cannabis products and is known for its psychoactive effects.

Chemical Structure and Properties

ADB-5'Br-PINACA has a chemical structure that includes an indazole core, which is substituted at the 1-position with a carboxamide group. The carboxamide group is further substituted with a 5-bromo-1-pentyl group. The full chemical name of ADB-5'Br-PINACA is N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-bromopentyl)-1H-indazole-3-carboxamide.

Pharmacology

As a synthetic cannabinoid, ADB-5'Br-PINACA acts as a potent agonist at the CB1 and CB2 receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including mood, memory, and pain sensation. The activation of these receptors by ADB-5'Br-PINACA can lead to psychoactive effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.

Legal Status

The legal status of ADB-5'Br-PINACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in legislation aimed at controlling synthetic cannabinoids and other novel psychoactive substances.

Health Effects and Risks

The use of ADB-5'Br-PINACA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, anxiety, and psychosis. In severe cases, it can lead to seizures, renal failure, and even death. The variability in the potency and purity of synthetic cannabinoid products can increase the risk of overdose and other harmful effects.

Detection and Analysis

ADB-5'Br-PINACA can be detected in biological samples using various analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are used in forensic and clinical laboratories to identify the presence of synthetic cannabinoids in urine, blood, and other specimens.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Novel psychoactive substances